Clinical Trials on Diabetic Neuropathy in South Africa

Total 1162 results

Regeneron Pharmaceuticals
Sanofi

Completed

A Study to Evaluate the Safety and Efficacy of Subcutaneously Administered REGN475(SAR164877) in Patients With Sciatic Pain

Sciatica

United States
Cephalon

Completed

Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniation

Sciatica

United States, Australia
Carmot Therapeutics, Inc.
Carmot Australia First Pty Ltd

Recruiting

A Study of CT-388 in Otherwise Healthy Overweight and Obese Adults and Patients With Type 2 Diabetes Mellitus

Diabetes

Australia, Mexico
Harokopio University
Monash University; National and Kapodistrian University of Athens; University... and other collaborators

Recruiting

Promote Health With Digital Tools Among Adults With Type 2 Diabetes/Prediabetes and/or Hypertension (DigiCare4You)

Hypertension | PreDiabetes | Type 2 Diabetes

Albania, Bulgaria, Greece, Spain
University of Adelaide

Recruiting

Effects of an Evening PROtein PrEload on Metabolic Health in Night ShIfT Workers (PROPENSITy) (PROPENSITy)

Type 2 Diabetes | Shift-work Disorder

Australia
AstraZeneca

Terminated

GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes

Type 2 Diabetes

Italy, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
Garvan Institute of Medical Research

Completed

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

Type 2 Diabetes

Australia
University of South Carolina

Recruiting

SWITCH Diets Study: Self-monitoring With Internet Technology to Choose Healthy Diets (SWITCH)

Overweight and Obesity | Pre-diabetes

United States
Avera McKennan Hospital & University Health Center

Withdrawn

A Placebo-Controlled, Randomized, Safety and Efficacy Study to Evaluate the Change in Hemoglobin A1c Levels in Type 2 Diabetic Subjects While Taking Nutralin

Diabetes

United States
Avera McKennan Hospital & University Health Center
Vintek, LLC

Completed

A Study to Evaluate Glucose and Insulin Response to Nutralin

Diabetes

United States
GlaxoSmithKline

Withdrawn

Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy

Glomerulonephritis, Membranous

Australia, Spain, United States, Canada, Germany, Netherlands, France, United Kingdom, Czech Republic, Italy
Horizon Health Network
McGill University; University of Michigan; Carilion Clinic; Lawson Health Research... and other collaborators

Completed

Narcotic vs. Non-narcotic Pain Study Protocol

Carpal Tunnel

United States, Canada
AstraZeneca

Completed

A Phase 2b Diabetic Kidney Disease Study

Diabetic Kidney Disease

United States, Chile, Korea, Republic of, Japan, Argentina, Canada, Peru
Exonate Limited
Novotech (Australia) Pty Limited

Completed

A Study to Evaluate the Safety and Tolerability of EXN407

Diabetic Macular Edema

Australia
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Recruiting

MYPP-trial: Myo-inositol Supplementation to Prevent Pregnancy Complications in Women With Polycystic Ovary Syndrome. (MYPP)

Polycystic Ovary Syndrome | Preterm Birth | Preeclampsia | Gestational Diabetes Mellitus

Netherlands
Virginia Commonwealth University
United States Department of Defense; McGuire Veterans Hospital; Immersive Experience...

Recruiting

Virtual Walking Intervention for Neuropathic Pain in Spinal Cord Injury (VRWalk)

Neuropathic Pain | Spinal Cord Injuries

United States, Australia
Pfizer

Completed

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | NIDDM

United States
Allergan

Completed

Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema

Diabetic Macular Edema | Vitrectomy

United States, Australia
Pfizer

Completed

PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

United States
Regeneron Pharmaceuticals
Bayer

Active, not recruiting

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease (PHOTON)

Type 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes Mellitus

United States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
Novo Nordisk A/S

Completed

A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study (SWITCH PRO)

Diabetes Mellitus, Type 2

United States, Slovakia, Canada, South Africa, Puerto Rico, Poland
Medical University of South Carolina
National Institutes of Health (NIH)

Completed

Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients

Cardiovascular Diseases | Diabetes Mellitus | Medication Adherence

United States
Sanofi
Population Health Research Institute

Completed

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) (ORIGIN)

Diabetes Mellitus, Non-Insulin-Dependent

United States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
Zafgen, Inc.

Completed

Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes

Type 2 Diabetes Mellitus | Overweight and Obesity

Australia, New Zealand
Medical University of South Carolina

Completed

Time Restricted Eating on Cancer Risk (TREC)

Breast Cancer | Time Restricted Feeding | Pre-diabetes

United States
AstraZeneca

Recruiting

iCaReMe Global Registry (iCaReMe)

Heart Failure | Hypertension | Type 2 Diabetes | Chronic Kidney Disease

Greece, Peru, Mexico, Costa Rica, Ecuador, Egypt, Ghana, India, Indonesia, Kenya, Nigeria, Philippines, South Africa
Palmetto Retina Center, LLC

Completed

A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema (TREX-DME)

Diabetic Macular Edema

United States
Novo Nordisk A/S

Completed

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification (DUAL™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Russian Federation, Spain, Hungary, Mexico, Argentina, Slovakia, Greece, South Africa, Australia
Eli Lilly and Company

Completed

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes (LIRA-Ramadan™)

Diabetes Mellitus, Type 2 | Diabetes

India, Israel, Malaysia, South Africa, Algeria, Lebanon, United Arab Emirates
Hoffmann-La Roche

Recruiting

A Study to Evaluate the Efficacy and Safety of RO7434656 in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression (IMAGINATION)

Primary IgA Nephropathy

Korea, Republic of, Australia, Spain, United Kingdom, Taiwan, China, Japan, France, United States, Italy, Greece, Czechia, Singapore, Hong Kong, Argentina, Malaysia, Germany, Brazil, Poland, Canada
Black Hills Center for American Indian Health
University of Colorado, Denver; University of Washington; Missouri Breaks Industries... and other collaborators

Completed

Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians

Cardiovascular Diseases | Hypertension | Obesity | Diabetes Mellitus, Type 2 | Tobacco Use Cessation

United States
University of Adelaide

Completed

Intermittent Fasting for Metabolic Health, Does Meal Timing Matter?

Insulin Resistance | Type 2 Diabetes

Australia
Zafgen, Inc.

Terminated

An Efficacy and Safety Study of Beloranib in Obese Subjects With Type 2 Diabetes Mellitus

Obesity | Type 2 Diabetes

Australia
AstraZeneca
Eli Lilly and Company

Completed

Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy

Type 2 Diabetes Mellitus

Italy, Poland, Hungary, Mexico, Greece, Australia
University of Alabama at Birmingham

Recruiting

Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

Diabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, Gestational

United States
ActivX Biosciences, Inc.
Kyorin Pharmaceutical Co.,Ltd

Completed

Safety and Efficacy of Once-Daily KRP-104 in Type 2 Diabetics With Inadequate Glycemic Control on Metformin Alone (Synergy104)

Type 2 Diabetes

United States, Poland, Argentina, Russian Federation, Czech Republic, South Africa, Guatemala
Dionyssiotis, Yannis, M.D.
University of Thessaly

Completed

Sarcopenia and Diabetes Mellitus (SARCoDM)

Sarcopenia

Greece
Pfizer

Completed

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
AstraZeneca

Completed

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

Type 2 Diabetes

United States, Hungary, Mexico, South Africa, Romania, Poland
Novartis Pharmaceuticals

Recruiting

A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

Primary IgA Nephropathy

Japan, Korea, Republic of, United States, Denmark, France, Taiwan, Belgium, Israel, Thailand, Germany, India, Czechia, Malaysia, Argentina, Singapore, China, Australia, Norway, Turkey, United Kingdom, Brazil, Hong Kong, Netherlands, C... and more
Sydney Children's Hospitals Network
Johns Hopkins University; Children's Hospital of Philadelphia; University of... and other collaborators

Unknown

Charcot-Marie-Tooth Disease (CMT) Infant Scale (INC-6611)

Charcot-Marie-Tooth Disease

United States, Australia, Italy
Baxter Healthcare Corporation

Completed

IMPENDIA- PEN VS Dianeal Only Improved Metabolic Control In Diabetic CAPD and APD Patients (Impendia)

Diabetes | ESRD

Australia, Canada, New Zealand
AstraZeneca
Bristol-Myers Squibb

Completed

Evaluation of Dapagliflozin Taken Twice-daily

Type 2 Diabetes

South Africa, Germany, Hungary, Romania, Slovakia, Switzerland, Ukraine
University of Adelaide

Completed

Metabolic Phenotyping of Individuals Born Following Assisted Reproduction Techniques (IMPART)

Diabetes | Metabolic Syndrome

Australia
Sanford Health
University of Exeter; The Leona M. and Harry B. Helmsley Charitable Trust; Pacific...

Recruiting

General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery (PLEDGE)

Type 1 Diabetes | Celiac Disease

United States
Bayer

Completed

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD)

Chronic Kidney Disease

Belgium, Finland, France, China, Hong Kong, Switzerland, United States, Turkey, Greece, New Zealand, Poland, South Africa, Spain, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, ... and more
Novo Nordisk A/S

Completed

Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Israel, Poland, United Kingdom, Denmark, Spain, France, Austria, Norway, Russian Federation, Canada, Croatia, Argentina, South Africa, Australia, Ireland, Brazil, Finland
Sanofi

Terminated

Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus (SAMS)

Sleep Initiation and Maintenance Disorders

United States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
University of Adelaide

Completed

Hyperbaric Oxygen Therapy and Insulin Resistance (HOTAIR2) - Effect of One HBO Session. (HOTAIR2)

Obesity | Type 2 Diabetes

Australia

Clinical Trials on Diabetic Neuropathy in South Africa

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Equatorial Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations